Molecular Partners Ag (MOLN) Current Deferred Revenue (2020 - 2023)

Molecular Partners Ag (MOLN) has disclosed Current Deferred Revenue for 4 consecutive years, with $4.9 million as the latest value for Q4 2023.

  • Quarterly Current Deferred Revenue fell 26.57% to $4.9 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $4.9 million through Dec 2023, down 26.57% year-over-year, with the annual reading at $4.8 million for FY2023, 27.48% down from the prior year.
  • Current Deferred Revenue for Q4 2023 was $4.9 million at Molecular Partners Ag, down from $6.7 million in the prior quarter.
  • The five-year high for Current Deferred Revenue was $30.7 million in Q4 2021, with the low at $4.9 million in Q4 2023.
  • Average Current Deferred Revenue over 4 years is $12.5 million, with a median of $7.2 million recorded in 2020.
  • The sharpest move saw Current Deferred Revenue surged 296.54% in 2021, then crashed 78.33% in 2022.
  • Over 4 years, Current Deferred Revenue stood at $7.7 million in 2020, then soared by 296.54% to $30.7 million in 2021, then plummeted by 78.33% to $6.7 million in 2022, then decreased by 26.57% to $4.9 million in 2023.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $4.9 million, $6.7 million, and $30.7 million for Q4 2023, Q4 2022, and Q4 2021 respectively.